How bacteria in tsetse flies affect the spread of sleeping sickness.
Endosymbiont mediated chitin catabolism in the tsetse fly gut impacts trypanosome transmission
This study is looking at how the bacteria in the stomachs of tsetse flies affect their ability to spread sleeping sickness, with the hope that understanding this could help find better ways to stop the disease from spreading to people.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10735887 on NIH RePORTER |
What this research studies
This research investigates the role of bacteria in the gut of tsetse flies and how they influence the transmission of African trypanosomiasis, also known as sleeping sickness. The study focuses on understanding the interactions between the tsetse fly's gut environment and the trypanosome parasites that cause the disease. By examining the composition of the gut bacteria and their effects on the fly's ability to transmit the parasites, the research aims to uncover new strategies for controlling the disease. Patients may benefit from insights that could lead to improved methods for reducing the spread of this serious illness.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals living in regions where sleeping sickness is endemic, particularly in sub-Saharan Africa.
Not a fit: Patients who do not reside in areas affected by sleeping sickness or who are not at risk of infection may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for controlling the transmission of sleeping sickness, potentially reducing the incidence of the disease in affected populations.
How similar studies have performed: Previous research has shown success in understanding the role of gut bacteria in other vector-borne diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Weiss, Brian L — Yale University
- Study coordinator: Weiss, Brian L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.